Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas
Elizabeth W. Gilloon Professor of Chemistry, California Institute of Technology (CalTech)
Executive Director, Kaiser Permanente Research Bank
Professor, University Of Toronto
Senior Director, Research and Development, Agena Biosciences
Professor and Director, The Scripps Research Institute
Senior Vice President And Chief Technology Officer, Illumina Inc
Associate Professor, University of California San Diego
Clinical Professor of Neurosciences and Pediatrics, Rady Children's Hospital in San Diego
Professor, University of California San Diego
Professor, University Of California-Los Angeles
Professor, The Scintillon Institute
This conference brings together technology development and clinical diagnostics applications of:
- Next-Generation Sequencing (NGS)
- Single Cell Analysis (SCA)
- Mass Spectrometry
Technology development in these fields is occurring in parallel with advances in Lab-on-a-Chip/Microfluidics and the broader push in diagnostics development, and in this vein this conference is co-located and concurrent with the following two conferences at the same venue and at the same time:1. Lab-on-a-Chip, Microfluidics and Microarrays World Congress
2. Point-of-Care Diagnostics and Global Health World Congress
It has become increasingly apparent that the differences between cells in the same population can be significant, and there is therefore a need for improved methods to capture and analyze individual cells such as circulating tumor cells (CTCs), cancer stem cells (CSCs), and the study of single cells for Companion Diagnostics (CDx) development. The development of technologies for single cell analysis (SCA) is driving this field forward vis-à-vis basic research on isolated individual cells, the development of biomarker assays, and diagnostics development.
We also explore at this conference the translation of next-generation sequencing (NGS) from research to deployment in the clinical-setting for oncology, genetic testing, as well as infectious disease testing. As NGS permeates the cancer biomarker and genetic testing realms and cost of NGS declines, there is the opportunity and hope to deploy NGS as a means to personalize diagnostics and therapeutics -- this is one of the themes explored in the NGS section of this conference.
This conference will also present the latest technologies/products in flow cytometry, FISH, immunomagnetic capture, and other approaches for SCA as well as NGS (including front-end sample preparation, RNA-Seq, Non-Invasive Prenatal Testing, and back-end data analysis) via technology spotlight presentations and exhibitors in the co-located exhibit hall.
Additionally, this conference highlights the emerging themes and translation of Mass Spectrometry from a Research Tool towards Clinical Deployment for Diagnostics. Topics addressed range from the use of mass spectrometry for studying small molecules in vivo
as a means for diagnostics development to the use of mass spectrometry to interrogate protein-based biomarkers. Presentations will highlight the front-end sample preparation challenges as they relate to the analysis of clinical samples via mass spectrometry and the diversity of clinical samples and bio-fluids will be explored.
Registered conference delegates have access to the additional co-located parallel conferences. This provides conference delegates the ability to Mix-and-Match Tracks, Topics, and Presentations as well as Maximizing Networking Opportunities.
The Exhibit Hall is Co-Located with the Conference Tracks in the Conference Center for Excellent Networking Opportunities and a Large Number of Leading-Edge Companies from Around the World will be Displaying their Technologies, Products and Services. Excellent opportunity for business development, partnering, and sales venue for vendors in these fields. Exhibit Hall is Open all day on September 29 and 30, 2015.Present Your Research in a Poster at this Conference. Poster Submission Deadline: September 22, 2015.
- Flow Cytometry, FISH and Technologies for Single Cell Analysis (SCA)
- Front-end Sample Preparation for NGS -- Challenges with Clinic Samples
- LC/MS for Clinical Diagnostics
- Mass Spectrometry for Biofluid Biomarker Analysis
- Mass Spectrometry for Biomarker Discovery and Validation
- New Technology Development in NGS
- Informatics and Data Handling/Analysis
- Instrumentation Platforms
- Reagent Offerings
- NGS for Clinical Testing
- NGS for Genetic Testing
- NGS in Non-Invasive Prenatal Testing (NIPT)
- Oncology and the Penetrance of NGS in Cancer Mutation Discovery
- NGS for Development of Therapeutic Antibodies and Vaccines
- NGS on Rare Cells (such as Circulating Tumor Cells)
- Novel Tools and Technologies for Single Cell Analysis (SCA)
- FISH for SCA and mRNA Localization/Enumeration at the Single Cell Level
- Front-End Sample Preparation for Single Cell Analysis
- Label-Free Routes to Single Cell Analysis
- Microfluidic Devices for SCA
- Single Cell Transcriptomics and Proteomics
- Regulatory Trends on Diagnostic Tests Developed using Mass Spectrometry: What is the Regulatory Pathway?
- Sample Preparation for Mass Spectrometry — Challenges Posed by Clinical Samples and the Need for Robustness, Scale and Automation
- Single Cell Analysis (SCA) for Diagnostics Development and Genetic, Prenatal Testing
- Single Cell Analysis (SCA) in Cancer, CNS Diseases, and Other Disease Classes
Sponsorship and Exhibition Opportunities
Jeff Fan, Exhibition Manager
Confirmed Speakers to date
Jeroen A. van Kan, Professor, Centre for Ion Beam Applications, Physics Department, National University of Singapore
Haim Bau, Professor, University Of Pennsylvania
Mark Connelly, Scientific Director, Janssen Diagnostics/Johnson & Johnson
Richard Gray, Regional Director, Blacktrace, Inc.
Stephen Jacobson, Professor, Indiana University
Mohit Jain, Assistant Professor, University Of California San Diego
Eric Kaldjian, Chief Medical Officer, RareCyte
Selena Larkin, Vice President, Marketing and Sales, SISCAPA/Omicia
Shaun Lonergan, Vice President/General Manager, Metabolon Inc
Frank Ong, Executive Director, Medical Affairs and Clinical Development, NantHealth
Vincenzo Pucci, Principal Scientist, Preclinical Bioanalytical Group, Merck Research Laboratories
Lidong Qin, Professor, CPRIT Scholar, Houston Methodist Research Institute
Naveen Ramalingam, Scientist II, Fluidigm Corporation
John Ryals, President And CEO, Metabolon Inc
Michael Scott, Clinical Market Development Manager, Agilent Technologies, Inc.
Richard Stahl, Senior Researcher, IMEC VZW
Austin Swafford, Field Application Scientist, Labcyte Inc
Charles Wang, Director & Professor, Loma Linda University
Shunqiang Wang, Research Assistant, Department of Mechanical Engineering & Mechanics, Lehigh University
David Weiss, Field Application Scientist, Agilent Technologies Inc
Chris Wetzel, Director of Sales and Marketing, MMI Microscope-based Single Cell Isolation
Benjamin Yellen, Associate Professor, Biomedical Engineering, Mechanical Engineering and Materials Science, Duke University
Yong Zeng, Assistant Professor, University of Kansas
All Delegates, Speakers, and Exhibitors Receive as Part of the Conference Materials Package, the Most Up-to-Date Publications/Articles, PowerPoint Presentations, and Review Articles focusing on the Next-Generation Sequencing (NGS) and Single Cell Analysis (SCA) Fields. Excellent to Bring Back to the Office and Use as Reference Materials for Publications, R&D Presentations, Business Plans, and User Manuals. Downloadable via conference cloud -- download details in the conference proceedings.